Cancer Institute (WIA) Adyar, Chennai

Cancer Institute (WIA), Adyar, Chennai is a comprehensive specialist oncology institution established in 1954 and recognised as a Regional Cancer Centre and State Cancer Institute. The institute combines cancer treatment with research, preventive oncology, education and charitable care. Its clinical services span surgical, medical and radiation oncology, paediatric oncology and other cancer-specific treatment, supported by diagnostic, pathology, rehabilitation and palliative-care services.

The institute’s current inpatient information lists 545 inpatient beds plus 131 semi-occupancy beds across its patient-care campuses. This distinction is more accurate than treating older total-bed figures as a single current inpatient capacity. The Cancer Institute has a long history of oncology innovation and continues to integrate clinical treatment with research and preventive-cancer programmes.

Inpatient care is delivered across two campuses in Adyar, the Dr. S. Krishnamurthi campus and the Dr. V. Shanta campus. Accommodation includes general wards and special wards with single-occupancy and twin-sharing rooms, exclusive blocks for children, and a day-care area for chemotherapy. The institute's Molecular Oncology Department is designated a Centre of Excellence by the Department of Science and Technology, Government of India.

The radiation oncology department offers external beam therapy including 3D conformal radiotherapy, IMRT and RapidArc therapy, along with stereotactic body radiotherapy (SBRT), total body radiation, electron treatment and brachytherapy. The institute also runs a bone bank, registered with the Government of Tamil Nadu and with TRANSTAN, which occupies about 1,600 square feet and supplies human bone allografts such as deep-frozen femoral heads and long bones and lyophilised bone blocks, used in areas including bone-tumour and spine surgery.

It is NABH accredited. For patients comparing cancer hospitals in South India, the Adyar Cancer Institute is particularly relevant for comprehensive oncology, paediatric cancer, research-linked treatment and patients seeking care in a long-established not-for-profit specialist institution.